Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Breast Neoplasms 168Neoplasms 132Prostatic Neoplasms 71Lung Neoplasms 67Colorectal Neoplasms 65Motor Activity 39Uterine Cervical Neoplasms 36Pancreatic Neoplasms 30Ovarian Neoplasms 27Head and Neck Neoplasms 27Brain Neoplasms 25Carcinoma, Non-Small-Cell Lung 23Rectal Neoplasms 21Glioblastoma 20Colonic Neoplasms 20Carcinoma, Hepatocellular 20Stomach Neoplasms 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Disease 16Depression 16Anxiety Disorders 16Hematologic Neoplasms 15Melanoma 14Leukemia 14Papillomavirus Infections 13Squamous Cell Carcinoma of Head and Neck 12Multiple Myeloma 12Glioma 12Carcinoma, Renal Cell 12Urinary Bladder Neoplasms 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Coronary Artery Disease × 30 days × Clear all
NCT04726319 2026-05-06

FHAMe

University of Toronto

Phase NA Completed
627 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Coronary Artery Disease, Diabetes Mellitus, Type 2, Melanoma, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡